|Articles|July 1, 2001
- Pharmaceutical Technology-07-02-2001
- Volume 25
- Issue 7
The BCS: Where Do We Go From Here?
The Biopharmaceutics Classification System, which is used to regulate the bioequivalence of oral drug products, may become an essential tool in future drug development efforts.
Advertisement
Articles in this issue
almost 25 years ago
Musings on the Past 25 Yearsalmost 25 years ago
Reflections on Changes at FDAalmost 25 years ago
Deliver the Dosealmost 25 years ago
Middle-European Pharmaceutics in a Changing Worldalmost 25 years ago
From Inactive Ingredients to Pharmaceutical Excipientsalmost 25 years ago
Am I Going Backwards?almost 25 years ago
The Filter Scene: Old and Newalmost 25 years ago
Catching Up with Expert Systemsalmost 25 years ago
25 Years of Change in the Parenteral Technology FieldAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Is Compliant AI in Pharma Even Possible? The Search for an Honest Answer
3
Sustainability by Design: Re-Imagining Amorphous Dispersion Manufacturing
4
What's Driving Biopharma M&A Strategy in 2026
5